Back to Dashboard

MK3543-007

MPN•MK3543-007•Last updated: 3/7/2026
Recruiting

Study Design

Study Drug

MK-3543 (Bomedemstat)

Mechanism of Action

LSD1

Sponsor

Merck Sharp & Dohme LLC (MSD)

Design

III

Control Arm

Hydroxyurea(placebo)/MK3543

Criteria

Inclusion Criteria

untreat

Age: Phase: III

Exclusion Criteria

Enrollment

Progress0 / 0

Contact Information

Principal Investigator

陳彩雲

Study Nurse

李佳玲

Contact Tel

4620